U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06943469) titled 'Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function' on March 17.
Brief Summary: The main purpose of this study is to assess the efficacy of a partially hydrolyzed formula with synbiotics in halting one of the first steps of the allergic march (atopic dermatitis) in infants at risk of allergy. Other efficacy and safety parameters will be assessed as well.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis (AD)
Intervention:
OTHER: Test formula
Partially hydrolyzed formula with synbiotics
OTHER: Control formula
Intact protein formula without synbiotics
Recruitmen...